J & J Vaccine and Blood Clots: A Risk, if It Exists, Is Tiny

Out of an “abundance of caution,” the F.D.A. is advising doctors to pause the Johnson& Johnson vaccine while it investigates extremely rare blood clots.

Source: NYT Health - April 13, 2021 Category: Consumer Health News Authors: Denise Grady and Carl Zimmer Tags: Vaccination and Immunization Blood Blood Clots Regulation and Deregulation of Industry Coronavirus (2019-nCoV) Food and Drug Administration Centers for Disease Control and Prevention AstraZeneca PLC Johnson & Source Type: news